![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1271, 2001-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
ACE inhibitors preferable in hypertension?
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gene therapy for pulmonary hypertension?
Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Thrombolysis with alteplase preferable to standard stroke therapy?
Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Arginine for SCD-associated pulmonary hypertension?
Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adherence-improving strategy cost effective for hypertension?
Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. :